Estrogen content represents a tradeoff between cycle control and side effects, but few direct
comparisons of 20 and 30/35 μg preparations are available. To address this issue, we …

Objective: To highlight studies that investigated the efficacy, safety, and tolerability of low-
dose oral contraceptives (OCs) containing 20 μg of ethinyl estradiol (EE) and to discuss the …

Concern about estrogen-related adverse effects has led to progressive reductions in the
estrogen dose in combination oral contraceptives (COCs). This review of randomized …

BACKGROUND: A cross-study analysis of contraceptive clinical trials for two different 91-day
oral contraceptive (OC) regimens was performed to examine the impact on bleeding …

OBJECTIVE: To assess the efficacy, safety, and tolerability of an extended-duration,
combined hormonal oral contraceptive pill (OCP) that reduces the estrogen exposure by …

BACKGROUND: This clinical trial was conducted to demonstrate the efficacy and safety of a
91-day extended-regimen, low-dose combination oral contraceptive (OC) consisting of 84 …

Objective To compare two oral contraceptive pills, both containing 150 μg desogestrel, but
with either 20 μg (Mercilon®) or 30 μg (Marvelon®/Desolett®) ethinyl oestradiol (EE) …

Extended-cycle oral contraceptives (OCs) are increasing in popularity in the United States. A
new extended-cycle OC that contains the lowest doses of ethinyl estradiol (EE) and …

The need to seek improved combined oral contraceptive (COC) efficacy, with fewer health
risks and better acceptability, has been ongoing since the introduction of COCs more than …

BACKGROUND: This open-label, noncontrolled study assessed the long-term efficacy and
tolerability of the monophasic combined low-dose oral contraceptive (OC) ethinyl estradiol …